Among those with preexisting SUDs, GLP-1s were linked to lower risks of emergency room visits, hospitalizations, mortality, overdose, and suicidal thoughts or attempts
Because these patches are not standardized or FDA-approved, there are no consistent dosing or wear-time guidelines, which is one reason clinicians recommend caution
Frequently Asked Questions What's the single most important question to ask before starting a GLP-1 via telehealth
Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
That does not make it a GLP-1 medication